Thione's mission is to design, develop and commercialize patented
preventative and therapeutic healthcare products and applications
utilizing synergistic antioxidant, anti-inflammatory and anti-viral
compositions in novel delivery systems.
The Company has identified numerous and diverse applications that
exploit the benefits of the Thione Complex. As a result of
Management's analysis of the status of these applications in terms
of necessary clinical data support and potential commercial partners,
Management is initially focusing its commercialization efforts on
the following product groups; Oral Care, Immune Building, Dermatologics,
Pain Relief and Cosmetics The Company believes that focusing on
these more "mature" applications will result in commericial
validation of the Company's technology while providing the Company
the time and resources to continue developing its base of clinical
test results for other promising applications.
The Company's topical and barrier applications conform to the Food
and Drug Administrations ("FDA") Drug and Cosmetic Act
and its oral care and immune building applications conform to the
FDA's Dietary Supplement Health and Education Act of 1994, significantly
shortening the time frame necessary to bring its technology to market.